Companies / Imunon, Inc.

Imunon, Inc.

Nasdaq: IMNNCIK 749647LAWRENCEVILLE, NJ

Financials · FY2022

Revenue$500.0K
Net income$-14.50M
Total debt$6.08M
Cash$6.86M
Diluted EPS$-6.83
Shares outstanding5.6M

Ownership

5.6M shares outstanding · as of Aug 10, 2026
1.5%Insiders
Ownership
Insiders1.48%83,091
10%+ / strategic6.24%349,917
Institutions3.16%177,044
Public float89.13%5,001,351

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Tardugno Michael HExecutive Chairman of Board · Director
1.07%59,986
Dentzer James EDirector
0.27%14,963
Pellizzari Christine ADirector
0.15%8,142
Anwer KhursheedChief Scientific Officer
——
Bragg KimberlyCFO
——
Braun Donald PDirector
——
Church Jeffrey WayneCFO
——
Eylward SusanGeneral Counsel and Corp Sec
——
Faller Douglas VincentChief Medical Officer
——
Fritz Frederick J.Director
——

Institutional holders 20

View all →
HolderValue% of shares
Armistice Capital, LLC$1.02M4.76%
Riverview Capital Advisers, LLC$247.8K0.61%
DRW Securities, LLC$224.1K1.05%
Vanguard Group Inc$141.2K0.66%
Geode Capital Management, LLC$97.6K0.59%
Wells Fargo & COMPANY/MN$13.1K0.06%
Morgan Stanley$11.3K0.05%
BlackRock, Inc.$7.9K0.08%
UBS Group AG$6.1K0.03%
SBI Securities Co., Ltd.$3.9K0.02%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$35.2K+12K
+56.49%
33,211
0.59% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
TrimCommon Stock$-57-15
-35.71%
27
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Armistice Capital, LLCPassive13G—349,917—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IMNNCommon StockEquity15117N701BBG000BJJGT8